Pfizer Chief Scientific Officer, Who Played Strategic Role In COVID-19 Jab Development, Will Step Down

Pfizer Chief Scientific Officer, Who Played Strategic Role In COVID-19 Jab Development, Will Step Down


Pfizer announced its Chief Scientific Officer Mikael Dolsten, who played a prominent role in developing the company’s experimental COVID-19 jab, will step down.

Dolsten will leave behind a 15-year career at the drug manufacturer.

Pfizer’s Chief Science Officer who developed COVID vaccines stepping down…he knows what’s coming! pic.twitter.com/jxB7rWdOms

— aussie17 (@_aussie17) July 9, 2024

Trending: Jovan Pulitzer: “Return Snipers Did NOT Kill Him” — “There Was A Second Malvo Shooter!”

Per Reuters:

Dolsten, aged 65, served as the head of Pfizer’s research and development after he joined the company through its $68 billion acquisition of Wyeth in 2009. He became the company’s chief scientist in 2010.

During his tenure, Comirnaty — jointly developed by Pfizer and BioNTech — became the first COVID vaccine to get an approval from the U.S. Food and Drug Administration in 2021, just 13 months after

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!